Weed (BUDZ) Change in Receivables (2018 - 2019)

Weed (BUDZ) posted quarterly Change in Receivables of $423.0 for Q2 2019, up 11.9% quarter-over-quarter from $378.0 in Q1 2019.

Weed (BUDZ) Change in Receivables (2018 - 2019) Analysis & Trends

Weed's Change in Receivables history runs 2 years deep, the most recent figure standing at $423.0 for Q2 2019.

In Q2 2019, Change in Receivables changed N/A year-over-year to $423.0; the TTM figure through Mar 2020 stood at $423.0 (up 6.02% YoY), while the FY2019 annual figure was $801.0, up 3714.29% from the prior year.
Change in Receivables for Q2 2019 stood at $423.0, up from $378.0 in the prior quarter.
The five-year high for Change in Receivables was $423.0 in Q2 2019, with the low at $21.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn	91.00 Mn
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn	66.00 Mn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-445.26 Mn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	-1.70 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	126.50 Mn
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	84.30 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	-
10	Weed	2.88 Mn	2.88 Mn	-	-

Download Data